Inhibition of Pseudomonas aeruginosa quorum sensing by chemical induction of the MexEF-oprN efflux pump.
Rasmus KristensenJens Bo AndersenMorten RybtkeCharlotte Uldahl JansenBlaine Gabriel FritzRikke Overgaard KiilerichJesper UhdThomas BjarnsholtKatrine QvortrupTim Tolker-NielsenMichael GivskovTim Holm JakobsenPublished in: Antimicrobial agents and chemotherapy (2024)
The cell-to-cell communication system quorum sensing (QS), used by various pathogenic bacteria to synchronize gene expression and increase host invasion potentials, is studied as a potential target for persistent infection control. To search for novel molecules targeting the QS system in the Gram-negative opportunistic pathogen Pseudomonas aeruginosa , a chemical library consisting of 3,280 small compounds from LifeArc was screened. A series of 10 conjugated phenones that have not previously been reported to target bacteria were identified as inhibitors of QS in P. aeruginosa . Two lead compounds (ethylthio enynone and propylthio enynone) were re-synthesized for verification of activity and further elucidation of the mode of action. The isomeric pure Z-ethylthio enynone was used for RNA sequencing, revealing a strong inhibitor of QS-regulated genes, and the QS-regulated virulence factors rhamnolipid and pyocyanin were significantly decreased by treatment with the compounds. A transposon mutagenesis screen performed in a newly constructed lasB-gfp monitor strain identified the target of Z-ethylthio enynone in P. aeruginosa to be the MexEF-OprN efflux pump, which was further established using defined mex knockout mutants. Our data indicate that the QS inhibitory capabilities of Z-ethylthio enynone were caused by the drainage of intracellular signal molecules as a response to chemical-induced stimulation of the MexEF-oprN efflux pump, thereby inhibiting the autogenerated positive feedback and its enhanced signal-molecule synthesis.
Keyphrases
- pseudomonas aeruginosa
- single cell
- gram negative
- gene expression
- cystic fibrosis
- biofilm formation
- multidrug resistant
- cell therapy
- transcription factor
- acinetobacter baumannii
- escherichia coli
- dna methylation
- crispr cas
- signaling pathway
- high throughput
- high glucose
- staphylococcus aureus
- photodynamic therapy
- genome wide
- stem cells
- cell migration
- candida albicans
- electronic health record
- cancer therapy
- human health
- risk assessment
- big data
- drug delivery
- data analysis
- reactive oxygen species